129 related articles for article (PubMed ID: 15179186)
21. Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.
Phillips JE; Hey JA; Corboz MR
Br J Pharmacol; 2003 Jan; 138(1):254-60. PubMed ID: 12522097
[TBL] [Abstract][Full Text] [Related]
22. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
[TBL] [Abstract][Full Text] [Related]
23. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
[TBL] [Abstract][Full Text] [Related]
24. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
[TBL] [Abstract][Full Text] [Related]
26. The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines.
Muñoz M; Rosso M; González-Ortega A; Coveñas R
Cancers (Basel); 2010 Apr; 2(2):611-23. PubMed ID: 24281084
[TBL] [Abstract][Full Text] [Related]
27. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
[TBL] [Abstract][Full Text] [Related]
28. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum.
Zagorodnyuk V; Santicioli P; Turini D; Maggi CA
Neuropeptides; 1997 Jun; 31(3):265-71. PubMed ID: 9243524
[TBL] [Abstract][Full Text] [Related]
29. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists.
Duffy RA; Varty GB; Morgan CA; Lachowicz JE
J Pharmacol Exp Ther; 2002 May; 301(2):536-42. PubMed ID: 11961054
[TBL] [Abstract][Full Text] [Related]
30. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines.
Muñoz M; Rosso M; Coveñas R
Pharmacol Rep; 2017 Aug; 69(4):696-701. PubMed ID: 28550801
[TBL] [Abstract][Full Text] [Related]
31. A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523.
Bonnet J; Kucharczyk N; Robineau P; Lonchampt M; Dacquet C; Regoli D; Fauchère JL; Canet E
Eur J Pharmacol; 1996 Aug; 310(1):37-46. PubMed ID: 8880065
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification.
Recio R; Vengut-Climent E; Mouillac B; Orcel H; López-Lázaro M; Calderón-Montaño JM; Álvarez E; Khiar N; Fernández I
Eur J Med Chem; 2017 Sep; 138():644-660. PubMed ID: 28710964
[TBL] [Abstract][Full Text] [Related]
33. Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro.
Holzer P; Lippe IT; Heinemann A; Barthó L
Neuropharmacology; 1998; 37(1):131-8. PubMed ID: 9680266
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
36. Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.
Mayordomo C; García-Recio S; Ametller E; Fernández-Nogueira P; Pastor-Arroyo EM; Vinyals L; Casas I; Gascón P; Almendro V
J Cell Physiol; 2012 Apr; 227(4):1358-66. PubMed ID: 21604273
[TBL] [Abstract][Full Text] [Related]
37. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
Munoz M; Recio S; Rosso M; Redondo M; Covenas R
J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
[TBL] [Abstract][Full Text] [Related]
38. Tachykinins mediate non-adrenergic, non-cholinergic excitatory neurotransmission to the hamster ileum via NK1 and NK2 receptors.
El-Mahmoudy A; Matsuyama H; Khalifa M; Shimizu Y; Takewaki T
Life Sci; 2003 Aug; 73(15):1939-51. PubMed ID: 12899919
[TBL] [Abstract][Full Text] [Related]
39. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
[TBL] [Abstract][Full Text] [Related]
40. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
